IN2013MU03221A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03221A
IN2013MU03221A IN3221MU2013A IN2013MU03221A IN 2013MU03221 A IN2013MU03221 A IN 2013MU03221A IN 3221MU2013 A IN3221MU2013 A IN 3221MU2013A IN 2013MU03221 A IN2013MU03221 A IN 2013MU03221A
Authority
IN
India
Prior art keywords
film
moisture
curving
sticky
melt
Prior art date
Application number
Other languages
English (en)
Inventor
Siraj Daud Anwar
Prakash Sapkal Nidhi
Nandkumar Bonde Minal
Original Assignee
Zim Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Lab Ltd filed Critical Zim Lab Ltd
Priority to EA201690751A priority Critical patent/EA038558B1/ru
Priority to UAA201605185A priority patent/UA123893C2/uk
Priority to CA2927334A priority patent/CA2927334C/en
Priority to BR112016008356-3A priority patent/BR112016008356B1/pt
Priority to MYPI2016701359A priority patent/MY184297A/en
Priority to PCT/IN2014/000652 priority patent/WO2015083181A2/en
Priority to IN3221MU2013 priority patent/IN2013MU03221A/en
Publication of IN2013MU03221A publication Critical patent/IN2013MU03221A/en
Priority to CL2016000880A priority patent/CL2016000880A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
IN3221MU2013 2013-10-14 2014-10-13 IN2013MU03221A (enExample)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EA201690751A EA038558B1 (ru) 2013-10-14 2014-10-13 Водорастворимая фармацевтическая пленка с повышенной стабильностью
UAA201605185A UA123893C2 (uk) 2013-10-14 2014-10-13 Водорозчинна фармацевтична плівка з підвищеною стабільністю
CA2927334A CA2927334C (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
BR112016008356-3A BR112016008356B1 (pt) 2013-10-14 2014-10-13 Processo/método para preparação de uma película solúvel em água de rápida dissolução oral e película oral fina
MYPI2016701359A MY184297A (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
PCT/IN2014/000652 WO2015083181A2 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
IN3221MU2013 IN2013MU03221A (enExample) 2013-10-14 2014-10-13
CL2016000880A CL2016000880A1 (es) 2013-10-14 2016-04-14 Recubrimiento farmacéutico soluble en agua con estabilidad mejorada

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3221MU2013 IN2013MU03221A (enExample) 2013-10-14 2014-10-13

Publications (1)

Publication Number Publication Date
IN2013MU03221A true IN2013MU03221A (enExample) 2015-07-03

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3221MU2013 IN2013MU03221A (enExample) 2013-10-14 2014-10-13

Country Status (8)

Country Link
BR (1) BR112016008356B1 (enExample)
CA (1) CA2927334C (enExample)
CL (1) CL2016000880A1 (enExample)
EA (1) EA038558B1 (enExample)
IN (1) IN2013MU03221A (enExample)
MY (1) MY184297A (enExample)
UA (1) UA123893C2 (enExample)
WO (1) WO2015083181A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3082767T3 (pl) * 2013-12-17 2025-02-24 Zim Laboratories Limited Mikroemulsje farmaceutyczne unieruchomione w cienkiej matrycy polimerowej i sposoby ich wytwarzania
AU2018241534A1 (en) * 2017-03-30 2019-09-26 Intelgenx Corp. Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
FR3082851B1 (fr) * 2018-06-25 2022-09-02 Biomerieux Sa Procede de detection et/ou d'identification d'au moins un microorganisme cible present sur une surface.
CN119015263B (zh) * 2024-08-20 2025-07-11 云南白药集团无锡药业有限公司 一种云南白药口溶膜剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (ja) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 加筆・修正可能なマツトフイルム
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
WO2006080630A1 (en) * 2004-09-23 2006-08-03 Handok Pharmaceuticals Co., Ltd. Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
CA2927334A1 (en) 2015-06-11
MY184297A (en) 2021-03-31
EA038558B1 (ru) 2021-09-14
CL2016000880A1 (es) 2017-01-27
UA123893C2 (uk) 2021-06-23
BR112016008356B1 (pt) 2022-12-13
WO2015083181A2 (en) 2015-06-11
EA201690751A1 (ru) 2016-08-31
CA2927334C (en) 2023-08-29
WO2015083181A3 (en) 2015-12-03
BR112016008356A2 (pt) 2017-08-01

Similar Documents

Publication Publication Date Title
IN2013MU03221A (enExample)
CY1120492T1 (el) Μια μορφοποιηση φαρμακου καθυστερημενης εκλυσης
BR112018073703A2 (pt) emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa
ECSP17046608A (es) Forma farmacéutica que incluye una solución sólida de drogas amorfas
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
AR063468A1 (es) Composiciones farmaceuticas
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
IL299897B1 (en) Devices and methods for administering multiple units of drug
MX2013003074A (es) Proceso de microencapsulacion y producto.
CY1119611T1 (el) Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος
MX2018002627A (es) Metodo de cristalizacion y biodisponibilidad.
DK3793534T3 (da) Oral tablet til levering af aktive ingredienser til mavetarmkanalen
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
WO2013013038A3 (en) Doping agents and polymeric compositions thereof for controlled drug delivery
PH12015502556A1 (en) Modified release formulation
WO2015107544A3 (en) Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
EP2371785A3 (en) Extrusion molding composition and method for producing extrusion molded part
BR112018067918A2 (pt) formulações livres de solvente de substâncias ativas com baixo ponto de fusão
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
BR112017002719A2 (pt) copolímero em bloco de lactídeo e método de preparação
EP3805200A4 (en) Self-assembled amino acid supramolecular polymer, preparation therefor, and application thereof
EP2978428A4 (en) STABLE NANO COMPOSITION WITH EPIRUBICIN, PROCESS FOR THE PRODUCTION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
PH12016500693B1 (en) Slow-release solid oral compositions
BR112015010243A2 (pt) dispersão sólida, composição para administração oral, composição farmacêutica, e, método para preparar uma dispersão sólida